NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Elicera Therapeutics AB (ST: ELIC)
ELIC Technical Analysis
4
As on 13th Jan 2025 ELIC STOCK Price closed @ 2.32 and we RECOMMEND Sell for LONG-TERM with Stoploss of 2.73 & Strong Sell for SHORT-TERM with Stoploss of 2.84 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ELICSTOCK Price
Open | 2.00 | Change | Price | % |
High | 2.48 | 1 Day | 0.33 | 16.58 |
Low | 1.96 | 1 Week | 0.65 | 38.92 |
Close | 2.32 | 1 Month | 0.58 | 33.33 |
Volume | 1049777 | 1 Year | -0.56 | -19.44 |
52 Week High 6.38 | 52 Week Low 0.85 |
ST Sweden Most Active Stocks
FING-B | 0.04 | -20.00% |
SBB-B | 4.88 | 3.83% |
KLAR | 0.67 | 123.33% |
QLINEA | 0.13 | -69.05% |
WYLD | 0.01 | 0.00% |
LIPI | 0.27 | -10.00% |
LUNE | 21.97 | 6.65% |
DIABIO | 0.02 | 0.00% |
TERRNT-B | 0.14 | -6.67% |
VEFAB | 1.92 | -10.28% |
ST Sweden Top Gainers Stocks
ST Sweden Top Losers Stocks
ELIC Daily Charts |
ELIC Intraday Charts |
Whats New @ Bazaartrend |
ELIC Free Analysis |
|
ELIC Important Levels Intraday
RESISTANCE | 3.32 |
RESISTANCE | 3.00 |
RESISTANCE | 2.80 |
RESISTANCE | 2.60 |
SUPPORT | 2.04 |
SUPPORT | 1.84 |
SUPPORT | 1.64 |
SUPPORT | 1.32 |
ELIC Forecast January 2025
4th UP Forecast | 3.82 |
3rd UP Forecast | 3.34 |
2nd UP Forecast | 3.04 |
1st UP Forecast | 2.75 |
1st DOWN Forecast | 1.89 |
2nd DOWN Forecast | 1.6 |
3rd DOWN Forecast | 1.3 |
4th DOWN Forecast | 0.82 |
ELIC Weekly Forecast
4th UP Forecast | 2.94 |
3rd UP Forecast | 2.74 |
2nd UP Forecast | 2.62 |
1st UP Forecast | 2.49 |
1st DOWN Forecast | 2.15 |
2nd DOWN Forecast | 2.02 |
3rd DOWN Forecast | 1.90 |
4th DOWN Forecast | 1.70 |
ELIC Forecast2025
4th UP Forecast | 14.63 |
3rd UP Forecast | 10.68 |
2nd UP Forecast | 8.24 |
1st UP Forecast | 5.8 |
1st DOWN Forecast | -1.16 |
2nd DOWN Forecast | -3.6 |
3rd DOWN Forecast | -6.04 |
4th DOWN Forecast | -9.99 |
Elicera Therapeutics AB ( ST Sweden Symbol : ELIC )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ELIC Other Details
Segment | EQ | |
Market Capital | 113971800.00 | |
Sector | Healthcare | |
Industry | Biotechnology | |
Offical website | > echo $website ; ?> |
ELIC Address
ELIC Latest News
ELIC Business Profile
Elicera Therapeutics AB, a clinical stage immuno-oncology company, engages in developing cell and gene therapies for immune-based cancer treatments in Sweden. The company's portfolio of products in pipeline include ELC-100, a Phase I/II drug candidate for neuroendocrine tumors indications; ELC-201, a preclinical drug candidate; ELC-301, a good laboratory practice TOX drug candidate for non-hodgkins lymphoma indications; and ELC-401, a preclinical drug candidate glioblastoma multiforme (brain tumor) indications. Its solutions also include iTANK (ELC-001 ), a platform technology for the immune enhancement of treatments. The company was founded in 2014 and is based in Göteborg, Sweden. Address: World Trade Center Göteborg, Göteborg, Sweden, 412 51
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service